These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5577247)

  • 1. [Arteriosclerosis--nicotinic acid therapy. 5. Acute effects in man].
    Svedmyr N; Aberg G
    Lakartidningen; 1971 Apr; 68(15):1753-7. PubMed ID: 5577247
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man.
    Svedmyr N; Harthon L; Lundholm L
    Clin Pharmacol Ther; 1969; 10(4):559-70. PubMed ID: 5793759
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arteriosclerosis and nicotinic acid therapy. 4. Nicotinic acid therapy].
    Ribom U
    Lakartidningen; 1971 Apr; 68(15):1750-2. PubMed ID: 5577246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis--nicotinic acid therapy. 12. Some effects on experimental animals].
    Brattsand R; Lindström E
    Lakartidningen; 1971 Apr; 68(15):1776-82. PubMed ID: 4325229
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of indomethacin on flush induced by nicotinic acid in man.
    Svedmyr N; Heggelund A; Aberg G
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):397-400. PubMed ID: 335786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of hyperlipemias with lipolytic drugs].
    Jover Sanz E; Paradinas Jiménez C; Corporales López L; Martínez Robles JV
    Rev Clin Esp; 1974 Jun; 133(5):447-50. PubMed ID: 4428087
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO
    Lakartidningen; 1971 Apr; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical-pharmacological studies on a new orally active adenosine derivative].
    Schaumann E; Kutscha W
    Arzneimittelforschung; 1972 Apr; 22(4):783-90. PubMed ID: 5068261
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the relation between the mobilization of free fatty acids (FFA) and diabetic acidosis: effects of nicotinic acid].
    Vecchi GP; Salvioli GF; Marani L
    Rev Atheroscler (Paris); 1968; 10(1):20-5. PubMed ID: 4971277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
    Sigroth K
    Lakartidningen; 1971 Apr; 68(15):1765-7. PubMed ID: 5577250
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of intravenous injection of heparin and nicotinic acid on (GG) plasma glyceride-glycerol and free fatty acids (FFA) level.
    Ruzyllo E; Szostak WB; Olszak W
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):52-3. PubMed ID: 5649940
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sorbinicate (nicotinic hexaester of D-glucitol) on the plasma FFA; plasma levels of nicotinic acid after sorbinicate administration.
    Avogaro P; Bittolo-Bon G; Cazzolato G
    Pharmacol Res Commun; 1978 Feb; 10(2):127-31. PubMed ID: 349572
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on normal subjects on the hemodynamic effects of nicotinic acid and of its higher homologue 3-pyridil-acetic acid. II. Behavior of cardiac rate, arterial pressure, cardiac output and oscillographic index].
    Giordano G; Verde AM; Cosentino F; Perroni L; Dagianti A
    Boll Soc Ital Cardiol; 1966; 11(2):224-8. PubMed ID: 5334139
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between the absorption of nicotinic acid and pentaerythritol tetranicotinate (Perycit) from ordinary and enterocoated tablets.
    Svedmyr N; Harthon L
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):66-74. PubMed ID: 5467756
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 19. Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.
    Harthon L; Svedmyr N
    Atherosclerosis; 1974; 20(1):65-8. PubMed ID: 4617581
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of the parenteral administration of nicotinic acid on the state of the cardiovascular system in patients with atherosclerosis].
    Savel'ev AA; Shershevskiĭ MG
    Klin Med (Mosk); 1965 Aug; 43(8):80-4. PubMed ID: 5868538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.